Form 4 Tracker
Jennifer Riley

Chief Strategy Officer · 4 filings · Latest: Aug 11, 2026

Avalo Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
AVTX
Jennifer RileyChief Strategy OfficerAug 11, 2026
Sale
$19.592,655$52.0K37,041
AVTX
JENNIFER RILEYAug 11, 2026
Proposed Sale
$19.592,655$52.0K